TopFunds

Becton Dickinson

NYSE: BDX

Stock price

182.75 USD

(+0%) TODAY

Health Care EquipmentMedical - Instruments & Supplies
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
3.4
4.5
4.6
0.6
3.9
2.7
6.9
5.9
4.9
5.9
5.8
5.7%
02Free cash flow per share
5.3
8.5
8.2
7.4
8.6
9.7
11.7
5.8
7.3
10.6
9.3
5.8%
03Dividends per share
1.8
2
2.2
2.3
2.4
2.4
2.5
2.7
2.9
3.2
3.5
6.6%
04Dividends payout, %
69.8%
57.6%
61.6%
3%
79.8%
1.2%
50.1%
60.8%
75.1%
64.5%
71.3%
0.2%
PROFIT AND LOSS STATEMENT
05Revenue
10,282
12,483
12,093
15,983
17,290
16,074
19,131
18,870
19,372
20,178
21,839
7.8%
06% Change
-
-
-
-
-
-
-
-
-
-
-
7.8%
07Cost of revenue
(5,587)
(6,492)
(6,128)
(8,714)
(9,002)
(9,276)
(10,500)
(10,393)
(11,202)
(11,053)
(11,915)
7.9%
08Gross profit
4,695
5,991
5,965
7,269
8,288
6,798
8,631
8,477
8,170
9,125
9,924
7.8%
09% Margin
45.7%
48%
49.3%
45.5%
47.9%
42.3%
45.1%
44.9%
42.2%
45.2%
45.4%
45.6% A
10Operating expenses
(3,621)
(4,561)
(4,443)
(5,760)
(6,528)
(5,886)
(6,381)
(6,195)
(6,059)
(6,728)
(7,347)
7.3%
11% of Revenue
(35.2)%
(36.5)%
(36.7)%
(36)%
(37.8)%
(36.6)%
(33.4)%
(32.8)%
(31.3)%
(33.3)%
(33.6)%
(34.9)% A
12Operating Income
1,074
1,430
1,522
1,509
1,760
912
2,250
2,282
2,111
2,397
2,578
9.2%
13Income tax expense
(44)
(98)
(124)
(862)
(57)
(62)
(88)
(148)
(132)
(300)
(204)
16.6%
14Net Income
695
976
1,100
311
1,233
874
2,092
1,779
1,484
1,705
1,678
9.2%
15% Margin
6.8%
7.8%
9.1%
2%
7.1%
5.4%
10.9%
9.4%
7.7%
8.5%
7.7%
7.5% A
16Shares Outstanding
207.5
217.5
223.6
264.6
274.8
282.4
292.1
287.4
288.4
291
287.1
3.3%
17EPS Basic
3.4
4.6
4.7
0.6
4
2.8
6.9
5.9
5
5.9
5.8
5.5%
18EPS Diluted
3.4
4.5
4.6
0.6
3.9
2.7
6.9
5.9
4.9
5.9
5.8
5.7%
19EBITDA
2,001
2,576
2,585
3,857
4,068
3,057
4,391
4,410
4,402
4,819
4,957
9.5%
% Margin
19.5%
20.6%
21.4%
24.1%
23.5%
19%
23%
23.4%
22.7%
23.9%
22.7%
22.2% A
20Net Interest Income (expense)
(356)
(367)
(445)
(641)
(627)
(521)
(460)
(382)
(403)
(365)
(575)
4.9%
21Net Debt / EBITDA
5.7
3.9
1.8
5.3
4.6
4.9
3.7
3.6
3.5
4.1
3.7
4.1 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
1,424
1,541
14,179
1,140
536
2,825
2,392
1,159
1,416
1,856
851
(5)%
23Short-term investments
95
366
37
17
30
20
12
8
8
445
8
(21.9)%
24Accounts receivable
1,693
1,618
1,744
2,319
2,345
2,398
2,350
2,191
2,534
3,033
2,994
5.9%
25Other current assets
563
1,123
871
1,484
1,174
983
1,341
1,559
1,445
1,291
1,508
10.4%
26Inventory
1,959
1,719
1,818
2,451
2,579
2,743
2,743
3,224
3,273
3,843
3,894
7.1%
27Total Current Assets
6,045
6,367
18,633
7,411
6,644
8,969
8,838
8,141
8,676
10,468
9,255
4.4%
Non-Current Assets
28Net property, plant & equipment
4,060
3,901
4,638
5,375
5,659
5,923
6,003
6,012
6,557
6,821
6,997
5.6%
29Long-term investments
1,118
796
38
-
-
-
-
-
-
-
-
(81.6)%
30Other non-current assets
15,641
14,524
14,425
41,119
39,441
39,120
39,038
38,778
37,547
39,997
39,073
9.6%
31Total Non-Current Assets
20,819
19,221
19,101
46,494
45,100
45,043
45,041
44,790
44,104
46,818
46,070
8.3%
Total Assets
26,820
25,586
37,734
53,904
51,842
54,012
53,880
52,934
52,780
57,286
55,325
7.5%
LIABILITIES
Current Liabilities
32Accounts payable
631
665
797
1,106
1,092
1,355
1,739
1,699
1,641
1,896
1,974
12.1%
33Short-term debt
1,452
1,001
203
2,601
1,309
706
626
2,297
1,258
2,312
1,560
0.7%
34Other current liabilities
2,298
2,734
2,342
3,509
3,254
3,775
4,261
3,815
3,742
4,748
4,779
7.6%
35Total Current Liabilities
4,381
4,400
3,342
7,216
5,655
5,836
6,626
7,811
6,641
8,956
8,313
6.6%
Non-Current Liabilities
36Long-term debt
11,370
10,550
18,667
18,894
18,081
17,224
17,798
14,654
15,566
19,274
17,621
4.5%
37Other non-current liabilities
3,562
3,002
2,777
6,800
6,947
7,187
5,765
5,187
4,776
3,167
4,002
1.2%
38Total Non-Current Liabilities
14,932
13,552
21,444
25,694
25,028
24,411
23,563
19,841
20,342
22,441
21,623
3.8%
39Total Liabilities
19,313
17,952
24,786
32,910
30,683
30,247
30,203
27,652
26,983
31,397
29,936
4.5%
SHAREHOLDERS` EQUITY
40Common stock
333
333
347
347
347
365
365
365
371
371
371
1.1%
41Retained earnings / (deficit)
12,314
12,727
13,109
12,594
12,912
12,791
13,826
15,157
15,535
16,139
16,622
3.1%
42Accumulated other comprehensive income / (loss)
(1,738)
(1,929)
(1,723)
(1,909)
(2,283)
(2,548)
(2,088)
(1,488)
(1,548)
(1,732)
(1,870)
0.7%
43Noncontrolling interests
-
-
-
-
-
-
-
-
-
-
-
-
44Total shareholders' equity
7,165
7,634
12,948
20,994
21,082
23,765
23,677
25,282
25,797
25,889
25,390
13.5%
45Total Liabilities and shareholders' Equity
26,820
25,586
37,734
53,904
51,842
54,012
53,880
52,934
52,780
57,286
55,325
7.5%
46Total Debt
12,822
11,551
18,870
21,495
19,390
17,930
18,424
16,951
16,824
21,586
19,181
4.1%
47Net Debt
11,398
10,010
4,691
20,355
18,854
15,105
16,032
15,792
15,343
19,730
18,330
4.9%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
695
976
1,100
311
1,233
874
2,092
1,779
1,484
1,705
1,678
9.2%
49Depreciation & amortization
891
1,114
1,088
1,978
2,253
2,154
2,273
2,229
2,288
2,286
2,462
10.7%
50Share-based compensation expense
166
196
174
322
261
236
229
233
259
247
258
4.5%
51Changes in working capital and other assets
(23)
273
188
254
(417)
275
53
(1,608)
(1,042)
(440)
(968)
45.4%
52Net cash flows from operating activities
1,729
2,559
2,550
2,865
3,330
3,539
4,647
2,633
2,989
3,798
3,430
7.1%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(633)
(718)
(727)
(895)
(957)
(810)
(1,231)
(973)
(874)
(725)
(760)
1.9%
54Purchases of investments / marketable securities
633
(1)
727
895
-
-
-
-
-
(421)
-
-
55Proceeds from maturities of marketable securities
840
718
13
11
-
-
-
-
-
-
422
(6.7)%
56Other investing activities
(9,158)
(668)
(896)
(15,840)
216
(422)
(649)
(2,258)
158
(4,368)
(480)
(25.5)%
57Net cash flows from investing activities
(8,318)
(669)
(883)
(15,829)
(741)
(1,232)
(1,880)
(3,231)
(716)
(5,514)
(818)
(20.7)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
-
(32)
4,607
-
-
2,917
(1,750)
(500)
-
(500)
(1,000)
46.6%
59Dividends paid, net
(485)
(562)
(677)
(927)
(984)
(1,026)
(1,048)
(1,082)
(1,114)
(1,100)
(1,196)
9.5%
60Debt issuance (repayments), net
6,655
(1,252)
7,282
1,090
(2,035)
(1,760)
(243)
(78)
(722)
3,775
(1,334)
-
61Other financing activities
21
85
(234)
(220)
(205)
(109)
(265)
1,069
(121)
(88)
(87)
-
62Net cash flows from financing activities
6,191
(1,761)
10,978
(57)
(3,224)
22
(3,306)
(591)
(1,957)
2,087
(3,617)
-
63Increase (decrease) in cash and cash equivalents
(437)
117
12,638
(13,039)
(646)
2,327
(525)
(1,233)
322
375
(1,005)
8.7%
64Cash and equivalents, ending balance
1,424
1,541
14,179
1,140
590
2,917
2,392
1,159
1,481
1,856
851
(5)%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
1,096
1,841
1,823
1,970
2,373
2,729
3,416
1,660
2,115
3,073
2,670
9.3%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Becton Dickinson (BDX) financial statements and performance

Explore Becton Dickinson (BDX) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.